Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Paired Central and Peripheral Blood Cultures for Febrile Neutropenia in Pediatric Patients With Cancer: Do We Need Peripheral Blood Cultures?
Journal: JCO oncology practice
Published: October 10, 2025
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.
Journal: Journal of the American Heart Association
Published: February 13, 2024
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials.
Journal: Thrombosis and haemostasis
Published: August 01, 2022
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.
Journal: Pediatric blood & cancer
Published: May 04, 2021
Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 11, 2020
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
Journal: The Lancet. Haematology
Published: June 05, 2020
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Journal: Blood
Published: May 14, 2019
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.
Journal: Clinical pharmacokinetics
Published: February 28, 2019
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 10, 2018
Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design.
Journal: Research and practice in thrombosis and haemostasis
Published: October 13, 2017
Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism.
Journal: Research and practice in thrombosis and haemostasis
Published: June 29, 2017
Last Updated: 09/26/2026